Glenzocimab
Product Specifications
CAS Number
2101829-58-5
Target
Others
Related Pathways
Others
Purity
1
Bioactivity
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1263787-01 0.02 mg (E-Coli)
Recombinant Pseudomonas putida N utilization substance protein B homolog (nusB)
Sign In for Pricing
View Details MBS1263787-02 0.1 mg (E-Coli)
Recombinant Pseudomonas putida N utilization substance protein B homolog (nusB)
Sign In for Pricing
View Details MBS1263787-03 0.02 mg (Yeast)
Recombinant Pseudomonas putida N utilization substance protein B homolog (nusB)
Sign In for Pricing
View Details MBS1263787-04 0.1 mg (Yeast)
Recombinant Pseudomonas putida N utilization substance protein B homolog (nusB)
Sign In for Pricing
View Details